德拉维特综合征患者的非药物治疗需求
Carla Ballesteros-Sayas1, Alicia Muñoz-Montero2, Simona Giorgi2
1Early Infant Care Center, Hospital San Rafael, C/ San Juan de Dios, 19, 18001 Granada, Spain.
Epilepsy & behavior : E&B
|November 30, 2023
概括
德拉维特综合征患者通常需要用于认知和运动问题的非药物疗法. 家庭经常承担这些必需治疗的全部费用,突出显著的社会经济负担.
科学领域:
- 神经学 神经学
- 遗传学 遗传学 是一个
- 罕见疾病 罕见疾病
背景情况:
- 德拉维特综合征 (DS) 是一种严重的遗传性,通常是由SCN1A基因突变引起的.
- DS呈现出耐药性,认知缺陷和行为障碍.
- 目前的研究缺乏关于DS的非药物干预措施的全面数据.
研究的目的:
- 调查在德拉维特综合征中使用的非药物治疗方法.
- 评估这些疗法对受影响家庭的社会经济影响.
主要方法:
- 一项在线调查分发给患有德拉维特综合征的人的照顾者.
- 收集的数据主要集中在非药物治疗类型和相关成本上.
主要成果:
- 超过91.9%的DS患者使用非药物疗法.
- 这些疗法主要针对认知,感官和运动障碍.
- 家庭经常承担这些治疗的全部经济成本.
结论:
- 非药物疗法对于管理德拉维特综合征至关重要,超出了管理范围.
- 家庭在提供必要的护理方面面临着巨大的经济挑战.
- 包括医疗保健和教育在内的全面支持对DS患者至关重要.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
314
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
314
Drug Therapy
45
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
45
Arteries of the Lower Limbs
192
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
192
Drug Delivery: Enteral Route
463
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
463
Factors Affecting Drug Response: Overview
2.0K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Parkinson's Disease: Treatment
276
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
276


